- Home
- INFA vs RVMD Comparison
INFA vs RVMD Comparison
Compare INFA & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INFA
- RVMD
- Stock Information
- Founded
- INFA 1993
- RVMD 2014
- Country
- INFA United States
- RVMD United States
- Employees
- INFA N/A
- RVMD N/A
- Industry
- INFA EDP Services
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INFA Technology
- RVMD Health Care
- Exchange
- INFA Nasdaq
- RVMD Nasdaq
- Market Cap
- INFA 7.6B
- RVMD 7.5B
- IPO Year
- INFA 2021
- RVMD 2020
- Fundamental
- Price
- INFA $24.85
- RVMD $60.86
- Analyst Decision
- INFA Hold
- RVMD Strong Buy
- Analyst Count
- INFA 12
- RVMD 17
- Target Price
- INFA $23.91
- RVMD $77.24
- AVG Volume (30 Days)
- INFA 1.3M
- RVMD 2.3M
- Earning Date
- INFA 11-05-2025
- RVMD 11-05-2025
- Dividend Yield
- INFA N/A
- RVMD N/A
- EPS Growth
- INFA N/A
- RVMD N/A
- EPS
- INFA 0.03
- RVMD N/A
- Revenue
- INFA $1,678,707,000.00
- RVMD N/A
- Revenue This Year
- INFA $5.43
- RVMD N/A
- Revenue Next Year
- INFA $4.92
- RVMD $537.73
- P/E Ratio
- INFA $733.48
- RVMD N/A
- Revenue Growth
- INFA 1.32
- RVMD N/A
- 52 Week Low
- INFA $15.65
- RVMD $29.17
- 52 Week High
- INFA $27.88
- RVMD $63.15
- Technical
- Relative Strength Index (RSI)
- INFA 49.69
- RVMD 77.76
- Support Level
- INFA $24.82
- RVMD $56.66
- Resistance Level
- INFA $24.89
- RVMD $63.15
- Average True Range (ATR)
- INFA 0.03
- RVMD 2.14
- MACD
- INFA -0.00
- RVMD 0.19
- Stochastic Oscillator
- INFA 37.50
- RVMD 79.24
About INFA Informatica Inc.
Informatica Inc provides artificial intelligence (AI) enabled data management products on a cloud native platform that connects, manages, and unifies data across multi-vendor, multi-cloud, and hybrid systems at an enterprise scale. The company's platform includes a suite of interoperable data management products that leverage the shared services and metadata of the underlying platform, including products for Data Catalog, Data Integration & Engineering, API & Application Integration, Data Quality and Observability, Master Data Management, Customer and Business 360 Applications, Governance, Access and Privacy, and Data Marketplace., allowing customers to track and understand their data. Geographically, the company generates maximum revenue from North America.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.